Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
Phase 3 Completed
546 enrolled 29 charts
Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
Phase 1 Completed
18 enrolled
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
Phase 3 Completed
1,501 enrolled 16 charts
Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer
Phase 2 Completed
87 enrolled 13 charts
Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
Phase 2 Completed
118 enrolled 14 charts
Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas
Phase 2 Completed
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Phase 3 Completed
506 enrolled 13 charts
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery
Phase 1/2 Completed
8 enrolled 9 charts
S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
Phase 1/2 Completed
134 enrolled 12 charts
Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma
Phase 1/2 Completed
46 enrolled 18 charts
Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer
Phase 1/2 Completed
17 enrolled 13 charts
Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer
Phase 2 Completed
154 enrolled
Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
Phase 2 Completed
82 enrolled
Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery
Phase 2 Completed
26 enrolled 9 charts
Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial
Phase 1 Completed
7 enrolled 17 charts
Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery
Phase 1 Completed
45 enrolled
AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor Cancers
Phase 1 Completed
23 enrolled
Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer
Phase 2 Completed
33 enrolled 9 charts
ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
31 enrolled
SGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Phase 2 Completed
30 enrolled 13 charts
Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
Phase 2 Completed
52 enrolled 8 charts
Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer
Phase 1/2 Completed
31 enrolled
Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer
Phase 2 Completed
21 enrolled 9 charts
Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery
Phase 2 Completed
137 enrolled 8 charts
Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer
Phase 2 Completed
143 enrolled 9 charts
Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors
Phase 1 Completed
37 enrolled
Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
18 enrolled
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
Phase 2 Completed
106 enrolled
Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
Phase 3 Completed
1,030 enrolled
Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors
Phase 1 Completed
21 enrolled
Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer
Phase 3 Completed
600 enrolled
3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer
Phase 2 Completed
Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
Phase 2 Completed
88 enrolled
3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Completed
30 enrolled
Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Phase 3 Completed
1,110 enrolled
Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery
Phase 2 Completed
254 enrolled
Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Phase 2 Completed
120 enrolled
3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
Phase 2 Completed
Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
Phase 2 Completed
50 enrolled
Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors
Phase 1 Completed
Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer
Phase 2 Completed
Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors
Phase 1 Completed
58 enrolled
Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Phase 2 Completed
35 enrolled
Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors
Phase 1 Completed
Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Phase 3 Completed
508 enrolled
Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer
Phase 2 Completed
33 enrolled
Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Phase 3 Completed
590 enrolled
Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
78 enrolled
Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Phase 2 Completed
48 enrolled
Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer
Phase 1 Completed
28 enrolled